• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Clover Health Investments Shares Are Trading Higher By 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

    3/13/24 1:18:56 PM ET
    $ADTH
    $AIRE
    $ANNX
    $ARQ
    Computer Software: Programming Data Processing
    Technology
    Real Estate
    Finance
    Get the next $ADTH alert in real time by email

    Shares of Clover Health Investments, Corp. (NASDAQ:CLOV) rose sharply during Wednesday’s session after the company reported better-than-expected fourth-quarter revenue results and issued FY24 insurance revenue guidance.

    Clover Health Investments reported quarterly sales of $510.3 million which beat the analyst consensus estimate of $480.25 million by 6.26% and represents a 43.22% decrease over sales of $898.79 million the same period last year.

    Clover Health Investments shares climbed 11.2% to $0.8537 on Wednesday.

    Here are some other stocks moving in today's mid-day session.

    Gainers

    • Gaxos.ai Inc. (NASDAQ:GXAI) shares jumped 128.9% to $12.18 after the company announced it acquired the rights to use certain AI-enabled technology from Ultiself.
    • Veritone, Inc. (NASDAQ:VERI) gained 52.4% to $2.6076 following strong sales results.
    • NuCana plc (NASDAQ:NCNA) gained 50.2% to $0.5869 after the company was granted a US Patent for "Phosphoramidate Derivatives For Use In The Treatment Of Cancer; Especially In The Treatment Where The Patient Shows Resistance."
    • The Beauty Health Company (NASDAQ:SKIN) rose 31.9% to $4.7350 after the company reported better-than-expected fourth-quarter revenue results.
    • Arq, Inc. (NASDAQ:ARQ) gained 28.3% to $4.4522 after the company reported upbeat fourth-quarter results.
    • MicroCloud Hologram Inc. (NASDAQ:HOLO) jumped 26.6% to $6.19.
    • Kintara Therapeutics, Inc. (NASDAQ:KTRA) shares gained 26.2% to $0.1055.
    • Nature's Sunshine Products, Inc. (NASDAQ:NATR) jumped 24.7% to $21.47 after the company reported better-than-expected fourth-quarter adjusted EPS results and issued FY24 net sales guidance.
    • Heron Therapeutics, Inc. (NASDAQ:HRTX) gained 24.7% to $2.9428 after the company reported better-than-expected fourth-quarter adjusted EPS results and issued FY24 revenue guidance. Also, Needham maintained a Buy rating on the stock and raised its price target from $4 to $5.
    • Li-Cycle Holdings Corp. (NASDAQ:LICY) shares gained 23.2% to $0.7233. Li-Cycle shares jumped 46% on Tuesday after the company entered an agreement to issue a senior secured convertible note in an aggregate principal amount of $75 million to an affiliate of Glencore.
    • Cue Biopharma, Inc. (NASDAQ:CUE) gained 19.2% to $2.11 after Jefferies initiated coverage on the stock with a Buy rating and $6 price target.
    • AdTheorent Holding Company, Inc. (NASDAQ:ADTH) surged 19% to $3.4150 following strong sales.
    • SIGA Technologies, Inc. (NASDAQ:SIGA) gained 18.8% to $6.32 after the company reported a year-over-year increase in quarterly financial results.
    • Educational Development Corporation (NASDAQ:EDUC) surged 18.1% to $2.0432.
    • Portage Biotech Inc. (NASDAQ:PRTG) gained 17.7% to $0.6589.
    • Williams-Sonoma, Inc. (NYSE:WSM) climbed 17.7% to $283.70 after the company reported better-than-expected fourth-quarter earnings, announced a new $ 1 billion stock repurchase authorization and increased its quarterly dividend.
    • HUTCHMED (China) Limited (NASDAQ:HCM) shares climbed 15.8% to $18.91 after gaining 9% on Tuesday.
    • Annexon, Inc. (NASDAQ:ANNX) rose 15% to $5.28. Needham analyst Joseph Stringer reiterated Annexon with a Buy and maintained a $16 price target.
    • Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) gained 13.2% to $8.90.
    • Full Truck Alliance Co. Ltd. (NYSE:YMM) climbed 11.2% to $7.74. Full Truck Alliance announced extension of share repurchase program up to $300 million.
    • Summit Therapeutics Inc. (NASDAQ:SMMT) gained 10% to $4.7450.
    • Qilian International Holding Group Limited (NASDAQ:QLI) climbed 10% to $0.6052.
    • PBF Energy Inc. (NYSE:PBF) gained 9.4% to $55.18.
    • BeiGene, Ltd. (NASDAQ:BGNE) shares climbed 9% to $178.44.
    • Minim, Inc. (NASDAQ:MINM) gained 8.3% to $5.43 after the company announced that it entered into a definitive merger agreement with e2Companies.
    • Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) rose 7% to $ 11.27.

    Losers

    • voxeljet AG (NASDAQ:VJET) shares fell 40.8% to $0.5922 after the company announced it will voluntarily delist its ADSs from Nasdaq and deregister its ADSs. The company also announced the restatement and extension of its loan financing with Anzu.
    • Luna Innovations Incorporated (NASDAQ:LUNA) fell 39% to $3.82 after the company announced that it will delay the release of its fourth-quarter and FY23 financial results. and said financial statements for the quarters ended Jun. 30 and Sept. 30 should no longer be relied upon.
    • SurgePays, Inc. (NASDAQ:SURG) fell 30.5% to $4.86 after the company reported worse-than-expected fourth-quarter financial results.
    • P3 Health Partners Inc. (NASDAQ:PIII) fell 29.4% to $0.72.
    • SOS Limited (NYSE:SOS) dipped 28% to $1.5399 G
    • Allbirds, Inc. (NASDAQ:BIRD) declined 25.3% to $0.6952 after the company reported worse-than-expected fourth-quarter GAAP EPS results.
    • Fangdd Network Group Ltd. (NASDAQ:DUO) fell 23.3% to $0.5710.
    • WideOpenWest, Inc. (NYSE:WOW) fell 21.1% to $2.7290 after the company reported worse-than-expected fourth-quarter financial results and issued guidance.
    • NaaS Technology Inc. (NASDAQ:NAAS) fell 20.1% to $1.19 after the company announced a $6 million registered direct offering.
    • Comtech Telecommunications Corp. (NASDAQ:CMTL) fell 19% to $4.6599. Comtech named John Ratigan as Interim Chief Executive Officer.
    • Aterian, Inc. (NASDAQ:ATER) tumbled 19% to $0.3783 following quarterly results.
    • Psyence Biomedical Ltd. (NASDAQ:PBM) fell 17.8% to $1.01.
    • reAlpha Tech Corp. (NASDAQ:AIRE) fell 16.3% to $1.07 after the company reported EPS for the eight months ended Dec. 31, 2023.
    • loanDepot, Inc. (NYSE:LDI) fell 15.9% to $2.1350 following weak quarterly results.
    • Bit Origin Ltd (NASDAQ:BTOG) fell 15.7% to $4.45 after gaining 11% on Tuesday.
    • Dollar Tree, Inc. (NASDAQ:DLTR) declined 14.5% to $128.00 after the company reported worse-than-expected fourth-quarter financial results and issued first-quarter EPS guidance below estimates.
    • Rackspace Technology, Inc. (NASDAQ:RXT) dipped 13.3% to $1.9150 after the company issued first-quarter guidance below estimates. The company also announced refinancing transactions.
    • ZIM Integrated Shipping Services Ltd. (NYSE:ZIM) fell 12.4% to $10.22 following weak quarterly sales.
    • Neumora Therapeutics, Inc. (NASDAQ:NMRA) declined 12.2% to $15.24.
    • ECD Automotive Design, Inc. (NASDAQ:ECDA) dipped 10.8% to $1.07 after jumping over 13% on Tuesday.
    • Solowin Holdings (NASDAQ:SWIN) fell 8.6% to $26.61.

     

    Now Read This: NVIDIA To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Wednesday

    Get the next $ADTH alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ADTH
    $AIRE
    $ANNX
    $ARQ

    CompanyDatePrice TargetRatingAnalyst
    Williams-Sonoma Inc.
    $WSM
    4/13/2026$218.00Neutral → Buy
    Goldman
    PBF Energy Inc.
    $PBF
    4/10/2026$49.00Neutral
    Goldman
    Summit Therapeutics Inc.
    $SMMT
    4/8/2026$45.00Buy
    Stifel
    Full Truck Alliance Co. Ltd.
    $YMM
    4/1/2026$8.00Underweight → Neutral
    Analyst
    Summit Therapeutics Inc.
    $SMMT
    3/16/2026$15.00Buy → Hold
    Jefferies
    Full Truck Alliance Co. Ltd.
    $YMM
    3/13/2026$9.00Buy → Neutral
    Daiwa Securities
    Dollar Tree Inc.
    $DLTR
    2/27/2026$132.00Buy → Neutral
    Citigroup
    Dollar Tree Inc.
    $DLTR
    2/17/2026$165.00Neutral → Buy
    Rothschild & Co Redburn
    More analyst ratings

    $ADTH
    $AIRE
    $ANNX
    $ARQ
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Williams-Sonoma upgraded by Goldman with a new price target

    Goldman upgraded Williams-Sonoma from Neutral to Buy and set a new price target of $218.00

    4/13/26 8:41:39 AM ET
    $WSM
    Home Furnishings
    Consumer Discretionary

    Goldman resumed coverage on PBF Energy with a new price target

    Goldman resumed coverage of PBF Energy with a rating of Neutral and set a new price target of $49.00

    4/10/26 8:34:03 AM ET
    $PBF
    Integrated oil Companies
    Energy

    Stifel initiated coverage on Summit Therapeutics with a new price target

    Stifel initiated coverage of Summit Therapeutics with a rating of Buy and set a new price target of $45.00

    4/8/26 8:38:26 AM ET
    $SMMT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADTH
    $AIRE
    $ANNX
    $ARQ
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Eicher Carol S bought $151,009 worth of shares (77,500 units at $1.95), increasing direct ownership by 80% to 174,010 units (SEC Form 4)

    4 - Arq, Inc. (0001515156) (Issuer)

    3/17/26 4:30:51 PM ET
    $ARQ
    Major Chemicals
    Industrials

    Gen Counsel, Corp Secretary Smith Claiborne Benson bought $3,836 worth of shares (2,000 units at $1.92), increasing direct ownership by 2% to 102,491 units (SEC Form 4)

    4 - Arq, Inc. (0001515156) (Issuer)

    3/16/26 5:32:38 PM ET
    $ARQ
    Major Chemicals
    Industrials

    Director Carson William H. bought $45,360 worth of shares (8,000 units at $5.67), increasing direct ownership by 15% to 62,405 units (SEC Form 4)

    4 - Annexon, Inc. (0001528115) (Issuer)

    3/12/26 4:31:34 PM ET
    $ANNX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADTH
    $AIRE
    $ANNX
    $ARQ
    SEC Filings

    View All

    SEC Form DEFA14A filed by Summit Therapeutics Inc.

    DEFA14A - Summit Therapeutics Inc. (0001599298) (Filer)

    4/17/26 5:00:01 PM ET
    $SMMT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 6-K filed by Psyence Biomedical Ltd.

    6-K - PSYENCE BIOMEDICAL LTD. (0001985062) (Filer)

    4/17/26 4:59:56 PM ET
    $PBM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form 8-A12B/A filed by Arq Inc.

    8-A12B/A - Arq, Inc. (0001515156) (Filer)

    4/17/26 4:33:38 PM ET
    $ARQ
    Major Chemicals
    Industrials

    $ADTH
    $AIRE
    $ANNX
    $ARQ
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Dergurahian Jeffrey Michael

    4 - loanDepot, Inc. (0001831631) (Issuer)

    4/17/26 4:31:13 PM ET
    $LDI
    Finance: Consumer Services
    Finance

    SEC Form 4 filed by Grassi Joseph J Iii

    4 - loanDepot, Inc. (0001831631) (Issuer)

    4/17/26 4:31:03 PM ET
    $LDI
    Finance: Consumer Services
    Finance

    SEC Form 4 filed by Graeler Darren

    4 - loanDepot, Inc. (0001831631) (Issuer)

    4/17/26 4:30:53 PM ET
    $LDI
    Finance: Consumer Services
    Finance

    $ADTH
    $AIRE
    $ANNX
    $ARQ
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for ZYNRELEF KIT issued to HERON THERAPS INC

    Submission status for HERON THERAPS INC's drug ZYNRELEF KIT (SUPPL-18) with active ingredient BUPIVACAINE; MELOXICAM has changed to 'Approval' on 11/21/2024. Application Category: NDA, Application Number: 211988, Application Classification: Labeling

    11/22/24 4:36:11 AM ET
    $HRTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    June 18, 2024 - FDA Roundup: June 18, 2024

    For Immediate Release: June 18, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA announced a request for input about patient safety associated with certain medical software functions excluded from the medical device definition. This input will help the FDA develop the 2024 report on the risks and benefits to health of non-devic

    6/18/24 3:16:28 PM ET
    $DLTR
    $AMGN
    Department/Specialty Retail Stores
    Consumer Discretionary
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    FDA Approval for APONVIE issued to HERON THERAPS INC

    Submission status for HERON THERAPS INC's drug APONVIE (SUPPL-3) with active ingredient APREPITANT has changed to 'Approval' on 03/05/2024. Application Category: NDA, Application Number: 216457, Application Classification: Labeling

    3/11/24 4:38:31 AM ET
    $HRTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADTH
    $AIRE
    $ANNX
    $ARQ
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Psyence BioMed Welcomes U.S. Executive Action to Advance Research into Ibogaine

    NEW YORK, April 17, 2026 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (NASDAQ:PBM) ("Psyence BioMed" or the "Company"), a clinical-stage biopharmaceutical company advancing nature-derived psilocybin and ibogaine therapies, today acknowledged recent reports that the U.S. administration is preparing an executive order to further evaluate the safety and therapeutic potential of ibogaine, a naturally occurring compound being studied for its potential in treating post-traumatic stress disorder (PTSD), addiction, and other serious neurological and mental health conditions. The anticipated executive action reflects growing recognition of the need for rigorous, regulated research into novel therap

    4/17/26 9:15:00 AM ET
    $PBM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Rackspace Technology to Announce First Quarter 2026 Earnings on May 7, 2026

    SAN ANTONIO, April 16, 2026 (GLOBE NEWSWIRE) -- Rackspace Technology® (NASDAQ:RXT) a leading end-to-end hybrid cloud and AI solutions company, today announced that it will release its first quarter 2026 financial results at 8:00 am ET on Thursday, May 7, 2026. Gajen Kandiah, Chief Executive Officer, and Mark Marino, Chief Financial Officer, will host a conference call on the day of the release (May 7, 2026) at 8:30 am ET to discuss the Company's financial results. Interested parties may access the conference call as follows: To listen to the live webcast or access the replay following the webcast, please visit our IR website at the following link: https://ir.rackspace.com/news-and-events

    4/16/26 5:22:23 PM ET
    $RXT
    Computer Software: Programming Data Processing
    Technology

    Gaxos Labs Expands AI Platform with Music Generation, AI Chat and 3D Model Creation, Driving Increased Engagement Across its AI Portfolio

    Latest rollout broadens Gaxos' generative AI markets as expanded capabilities fuel user activity and platform momentum Roseland, NJ, April 16, 2026 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various high-growth sectors, today announced the expansion of its Gaxos Labs product ecosystem with the addition of AI Music Generation, AI Chat, and AI 3D Model Creation capabilities. The rollout of these latest features has already contributed to an uptick in user engagement across its AI portfolio, reinforcing the strength of its product strategy and growing demand for practical, creativity-enhancing AI tools. The

    4/16/26 4:15:00 PM ET
    $GXAI
    Computer Software: Prepackaged Software
    Technology

    $ADTH
    $AIRE
    $ANNX
    $ARQ
    Leadership Updates

    Live Leadership Updates

    View All

    Rackspace Technology Appoints Paul Soligon and Marco Tesini to Senior Leadership Roles

    SAN ANTONIO, April 08, 2026 (GLOBE NEWSWIRE) -- Rackspace Technology® (NASDAQ:RXT), a leading end-to-end hybrid cloud and AI solutions company, today announced the appointments of Paul Soligon as Senior Vice President of Operations and Marco Tesini as Senior Vice President of International for the company's Private Cloud business unit. Soligon will be responsible for unifying key operational functions to drive growth and strengthen customer retention. In this role, he will lead Business and Sales Operations as well as Customer Success with a focus on advancing analytics and insights as well as elevating customer experience. Soligon brings extensive leadership experience from over 25 year

    4/8/26 8:15:00 AM ET
    $RXT
    Computer Software: Programming Data Processing
    Technology

    Clover Health Announces Departure of Chief Financial Officer and Appointment of Interim Chief Financial Officer; Reiterates Most Recently Issued Financial Guidance for Full Fiscal Year 2026

    WILMINGTON, Del., April 01, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ:CLOV) ("Clover" or the "Company"), a physician enablement company committed to bringing access to great healthcare to everyone on Medicare, today announced that Peter Kuipers is stepping down as the Chief Financial Officer of the Company, effective March 30, 2026. Mr. Kuipers will remain with the Company in an advisory capacity through April 24, 2026 to support a smooth transition and handoff. Mr. Kuipers and the Company noted that his departure does not reflect any disagreement with the Company on any matter relating to the Company's operations, policies or practices. The Board of Directors has

    4/1/26 8:30:00 AM ET
    $CLOV
    Medical Specialities
    Health Care

    Cue Biopharma Announces CEO Transition

    BOSTON, March 27, 2026 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (NASDAQ:CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage and modulate disease-specific T cells for the treatment of autoimmune and inflammatory diseases, today announced that Lucinda Warren, an industry veteran who has served as Cue Biopharma's chief financial and business officer since February 2026 and previously as Cue Biopharma's chief business officer from September 2024 until February 2026, has been appointed interim president and chief executive officer (CEO). Usman Azam has stepped down as president and CEO and as a director, effective March 26, 202

    3/27/26 4:05:00 PM ET
    $CUE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADTH
    $AIRE
    $ANNX
    $ARQ
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Fangdd Network Group Ltd.

    SC 13G - Fangdd Network Group Ltd. (0001750593) (Subject)

    12/16/24 4:26:40 PM ET
    $DUO
    Real Estate
    Finance

    Amendment: SEC Form SC 13G/A filed by Fangdd Network Group Ltd.

    SC 13G/A - Fangdd Network Group Ltd. (0001750593) (Subject)

    12/16/24 4:24:27 PM ET
    $DUO
    Real Estate
    Finance

    SEC Form SC 13G filed by Psyence Biomedical Ltd.

    SC 13G - PSYENCE BIOMEDICAL LTD. (0001985062) (Subject)

    12/13/24 9:16:01 AM ET
    $PBM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADTH
    $AIRE
    $ANNX
    $ARQ
    Financials

    Live finance-specific insights

    View All

    Rackspace Technology to Announce First Quarter 2026 Earnings on May 7, 2026

    SAN ANTONIO, April 16, 2026 (GLOBE NEWSWIRE) -- Rackspace Technology® (NASDAQ:RXT) a leading end-to-end hybrid cloud and AI solutions company, today announced that it will release its first quarter 2026 financial results at 8:00 am ET on Thursday, May 7, 2026. Gajen Kandiah, Chief Executive Officer, and Mark Marino, Chief Financial Officer, will host a conference call on the day of the release (May 7, 2026) at 8:30 am ET to discuss the Company's financial results. Interested parties may access the conference call as follows: To listen to the live webcast or access the replay following the webcast, please visit our IR website at the following link: https://ir.rackspace.com/news-and-events

    4/16/26 5:22:23 PM ET
    $RXT
    Computer Software: Programming Data Processing
    Technology

    loanDepot, Inc. to Report First Quarter 2026 Financial Results on May 5, 2026

    loanDepot, Inc. (NYSE:LDI) (together with its subsidiaries, "loanDepot" or the "Company"), a leading provider of products and services that power the homeownership journey, today announced that the Company will release its first quarter 2026 financial results on May 5, 2026, after market close. Management will host a conference call and live webcast at 5:00 p.m. ET. The call will include a review of financial results and operating highlights followed by a question-and-answer session. Register online in advance at https://events.q4inc.com/attendee/833959793. A live audio webcast of the conference call will also be available via the Company's website, investors.loandepot.com, under the Ev

    4/16/26 4:15:00 PM ET
    $LDI
    Finance: Consumer Services
    Finance

    P3 Health Partners Schedules First Quarter 2026 Earnings Release and Conference Call

    P3 Health Partners Inc. ("P3" or the "Company") (NASDAQ:PIII), a patient-centered and physician-led population health management company, today announced that the Company plans to release its financial results for first quarter 2026 on Thursday, May 14, 2026. In connection with the release, management will host a conference call to discuss the financial results at 1:30pm PT/ 4:30pm ET the same day. Title & Webcast P3 Health First Quarter 2026 Earnings Conference Call Date & Time May 14, 2026, 4:30pm Eastern Time Conference Call Details Toll-Free 1-833-316-0546 International 1-412-317-0692 Ask to be joined into the P3 Health Partners call

    4/16/26 4:05:00 PM ET
    $PIII
    Medical/Nursing Services
    Health Care

    $ADTH
    $AIRE
    $ANNX
    $ARQ
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    Financial Insight: Purchase at Clover Health Investments Corp. on Jun 20

    The recent insider purchase at Clover Health Investments Corp. by Director Garipalli Vivek on June 20, 2024, has caught the attention of investors. Director Garipalli Vivek bought $1,000,426 worth of shares, acquiring 877,567 units at $1.14 per share, as reported in SEC Form 4. This insider purchase stands out among recent insider transactions at Clover Health. Looking at the previous transactions, there have been instances of insiders covering exercise/tax liability by selling shares, resulting in a decrease in their direct ownership percentages. For example, Reynoso Jamie L., Priest Brady Patrick, Toy Andrew, Sharp Aric R, Soares Karen, Chief Technology Officer Wai Conrad, and CEO Reynoso

    6/20/24 6:36:05 PM ET
    $CLOV
    Medical Specialities
    Health Care